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n 1996, Richard Horton, editor 
of the Lancet, chastised much of 
current surgical research and, in 
particular, questioned the usefulness of 
the case series as a predominant form 
of communication among surgeons 
[1]. He asked a poignant question: 
“Does surgical research have a future?” 
Nearly a decade later, it is important 
for surgeons and non-surgeons alike to 
revisit Horton’s challenge.
Why Surgeons Favor Case Series
Randomized controlled trials (RCTs) 
have become the pillar of clinical 
research. Such trials attempt to obtain 
an unbiased randomization of patients 
with respect to known and unknown 
baseline conditions and to assess the 
effects of an intervention. However, 
only a minority of surgical studies 
involve a valid randomization scheme. 
The case series remains a favored 
method of clinical investigation in 
surgery.
Case series are easy to perform, 
require less resources in terms 
of personnel and funds, can be 
performed at a single center, and, for 
many surgeons, represent a means to 
illustrate their surgical method and 
skills. In many instances, case series 
also serve as valuable intellectual 
background for future clinical or 
scientiﬁ  c work. For example, consider 
Dennis Burkitt’s report on jaw tumors 
in African children, Alfred Blalock’s 
initial efforts in cardiac surgery, or, 
more recently, Starzl and colleagues’ 
observations, in a small collection of 
patients, of donor leukocyte chimerism, 
whereby recipients acquire tolerance to 
foreign donor cells. In all three cases, 
the authors’ work led to powerful shifts 
in our understanding of the biology 
and treatment of disease [2,3,4]. All 
were case reports or case series—but 
under the current paradigm adopted 
by most journals and evidence-based 
databases, they would not be valued 
[5,6,7].
Barriers to Surgical RCTs
There are many reasons why RCTs in 
surgical patients may be more difﬁ  cult 
to perform than those in non-surgical 
patients. One of the most important—
though least understood—is that the 
complexities of human disease in 
surgical patients makes them a more 
difﬁ  cult group to study. Surgical 
patients are often heterogeneous in 
many more ways than non-surgical 
patients. So it would be inherently 
easier, for example, to study a new 
medication for generally healthy young 
adults with essential hypertension 
than a surgical technique for older 
patients with hepatic failure needing 
transplantation.
In addition, while there may be value 
in studying patients from multiple 
centers, there may be important 
differences in the skill levels of 
different surgeons, either between 
centers or across the country. For 
example, the skill levels of surgeons in 
trials of carotid endarterectomy may be 
greater than those across the surgical 
community as a whole. This makes the 
applicability of some surgical RCTs to 
the wider community less certain than 
trials of medical therapies. 
So when it comes to surgical 
research, for both researchers and 
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funding agencies, it is easier to grapple 
with a difﬁ  cult, but ultimately soluble, 
basic science question than to face 
the uncertainty of clinical research. 
Investigators understand these implicit 
issues and trim their sails accordingly.
Improving the Rigor of Research
Nonetheless, too much surgical work 
is conducted in the less rigorous 
format of the case series. What can and 
should be done to improve the rigor 
of surgical investigation? It would seem 
that improvements are required from 
within and beyond the surgical world.
First, as Horner observed, and several 
eminent surgeons have since agreed, 
reforms must begin within the ﬁ  eld 
itself [1,5,6,7]. Both during surgical 
training and in the early years of faculty 
development, surgeons must obtain a 
thorough grounding in the principles 
of basic research and proper clinical 
investigation. 
Second, surgeons must establish 
ﬁ  rm and friendly relations with 
biostatisticians so that the latter may 
play a strong role in helping to develop 
adequately powered studies that can 
answer critical questions raised by new 
therapies and techniques. This is an 
especially acute need in an accelerating 
age of targeted therapies and disease 
biomarkers. 
Third, surgeons must re-engage in 
the clinical research enterprise and 
resume leadership roles in local and 
national clinical trials that involve 
surgical patients. In the United States, 
for example, an important step in this 
regard has been the establishment of 
the American College of Surgeons 
Oncology Group, which invites 
surgeons from all sectors, including 
private practice, to become active 
participants in well-designed, multi-
institutional trials [5]. Similar efforts 
are needed on a global level.
Finally, similar to the pressures 
faced by their colleagues elsewhere 
in academia, surgeon clinician-
investigators must be nurtured, 
protected, and valued by their 
colleagues and medical administrators. 
The ﬁ  nancial health of academic 
medical centers relies heavily on the 
generation of clinical revenue, which 
in many centers falls disproportionately 
on the shoulders of surgeons. New 
paradigms for revenue generation 
and funding of clinical research are 
needed.
Funding for Surgical Research
Beyond the walls of the academic 
medical center, there also needs to 
be greater recognition of the value of 
scientiﬁ  cally sound surgical research 
and clinical investigation. However, the 
National Institutes of Health (NIH), 
the major source of biomedical funding 
in the United States, continues to 
convey a less welcoming attitude toward 
surgical research than toward other 
types of clinical or basic science[8,9]. 
At the NIH, the principal instrument 
for performing peer review and making 
grant funding decisions is the study 
section, composed of about 10–20 
members with expertise in a given ﬁ  eld. 
There are few study sections devoted to 
surgically oriented clinical research and 
only two study sections (from among 
more than 100) in which surgeons 
make up even a reasonable minority 
of the committee members [8]. In 
comparison to those in other clinical 
departments, surgical grant proposals 
are less likely to be funded, and awards, 
when funded, are smaller [8].
Surgical research is also impeded 
by processes affecting other types 
of research as well. The number 
of researchers under 35 years of 
age receiving a ﬁ  rst RO1 grant, the 
main NIH mechanism for external 
funding, in any ﬁ  eld, is below 4%. The 
average age of initial funding for US 
physicians is about 44 years, and shows 
a trend toward advancing age that has 
progressed signiﬁ  cantly in the past two 
decades. Thus, the NIH appears to 
reward experience and proven results 
very heavily, which may stiﬂ  e innovation 
and likely serves as an innate barrier 
for younger physician-investigators 
contemplating research careers [9].   
To help correct for this worrisome 
trend, the NIH created the “K” award 
system—career development grants 
designed to help starting researchers 
gain the experience needed to compete 
for RO1 grants. However, nearly 40% 
of the clinicians who receive KO8 
awards never apply for RO1 funding 
[10], which suggests that the overall 
support—both explicit and implicit—
for clinical research at the institutional 
and funding levels is inadequate.
Finally, outside the US, surgeons face 
similar, if not greater problems. This 
bodes poorly for countries where the 
cost of evaluating new therapies and 
technologies may be an unaffordable 
luxury. These challenges to the surgical 
research enterprise are therefore global 
issues and should merit the attention 
of surgeons, medical institutions, and 
funding agencies in all countries.
The Future
What can be done? On the national 
and international level, funding 
agencies need to recognize the 
importance of the surgical endeavor 
to modern medicine. Recently, in the 
US the NIH unveiled a “roadmap” 
(http://nihroadmap.nih.gov) 
designed to provide “new pathways 
to discovery.” Clear, careful, scientiﬁ  c 
surgical investigation must be part 
of this roadmap, although it is not 
speciﬁ  cally mentioned. Outreach 
efforts to include surgeons in a variety 
of study sections should be made to 
ensure that important insights into 
the pathophysiology and treatment 
of disease, with which surgeons 
are concerned on a daily basis, are 
not overlooked. Additional efforts 
are needed to improve funding for 
clinical research, both for individuals 
at early stages of their careers 
and for multi-disciplinary clinical 
research and clinical trials. Locally, 
and individually, surgeons must 
join efforts to improve the clinical 
research enterprise by including 
training in clinical investigation at 
an early stage in medical school and 
during surgical residency training, 
fostering the careers of young surgeon-
investigators through committed, 
protected time, participating in local 
and national clinical research groups, 
and recognizing that development as 
a clinical researcher takes time—many 
years in fact.
These efforts may help ensure 
that surgical research is a vital part 
of the future of medicine and that it 
leads to the kind of high-quality work 
that shapes and remodels the face 
of medicine. To foster these efforts, 
surgeons must change and adapt 
to the currents of modern medical 
research. If this is successful, the case 
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series will become the occasional rather 
than the common form of surgical 
communication. And surgeons, other 
clinicians, and, most importantly, 
basic scientists will be better able to 
take advantage of the new avenues of 
biomedical science opening before us. 
But the case series will always 
represent one important tool for early 
studies or uncommon conditions. It 
remains true that while the method 
one uses inﬂ  uences the answer one 
receives, it can be just as important to 
ask the right questions, which can be 
asked even in a series of one patient 
[11]. And surely that is the place one 
must begin.  
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